LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:----------FTSE 100----------UBS CUTS RELX TO 'SELL' ('NEUTRAL')----------BARCLAYS CUTS PEARSON TO 'UNDERWEIGHT' ('EQUAL WEIGHT') - PRICE TARGET 815 (855) PENCE----------BERNSTEIN RAISES SSE TARGET TO 1310 (1280) PENCE - 'MARKET-PERFORM'----------UBS RAISES FERGUSON PRICE TARGET TO 6550 (5950) PENCE - 'NEUTRAL'----------SOCGEN CUTS WPP PRICE TARGET TO 1845 (1940) PENCE - 'BUY'----------BERENBERG RAISES HALMA PRICE TARGET TO 1570 (1410) PENCE - 'BUY'----------HSBC RAISES ASHTEAD GROUP PRICE TARGET TO 2850 (2420) PENCE - 'BUY'----------BARCLAYS CUTS STANDARD LIFE ABERDEEN TARGET TO 440 (460) PENCE - 'OVERWEIGHT'----------CFRA CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 4150 (5000) PENCE - 'HOLD'----------FTSE 250----------NUMIS CUTS PZ CUSSONS PRICE TARGET TO 230 (255) PENCE - 'HOLD'----------NUMIS RAISES AVEVA GROUP PRICE TARGET TO 2940 (2216) PENCE - 'ADD'----------HSBC CUTS FIRSTGROUP PRICE TARGET TO 80 (111) PENCE - 'HOLD'----------GOLDMAN CUTS PETS AT HOME PRICE TARGET TO 145 (198) PENCE - 'NEUTRAL'----------JPMORGAN RAISES WORKSPACE GROUP TARGET TO 1250 (1100) PENCE - 'OVERWEIGHT'----------RBC RAISES CAIRN ENERGY PRICE TARGET TO 400 (300) PENCE - 'OUTPERFORM'----------GOLDMAN RAISES BRITVIC PRICE TARGET TO 772 (765) PENCE - 'NEUTRAL'----------OTHER MAIN MARKET AND AIM----------NUMIS RAISES URBAN & CIVIC PRICE TARGET TO 410 (400) PENCE - 'BUY'----------LIBERUM RAISES MAJESTIC WINE PRICE TARGET TO 535 (500) PENCE - 'BUY'----------RBC CUTS CONSORT MEDICAL PRICE TARGET TO 1430 (1440) PENCE - 'OUTPERFORM'----------BERENBERG RAISES OXFORD INSTRUMENTS TO 'BUY' ('HOLD') - TARGET 1180 (1050) P----------JPMORGAN RAISES BIFFA PRICE TARGET TO 300 (290) PENCE - 'OVERWEIGHT'----------
Consort Medical splutters as BAT stubs out Voke programme
(ShareCast News) - British American Tobacco has terminated an agreement with Consort Medical over the manufacture of nicotine inhalers for its Voke development programme. Consort, which said it was in "constructive dialogue" with BAT's Nicovations arm and product developer Kind Consumer over the fut
Read more